601514-62-9Relevant academic research and scientific papers
SPIROUREA DERIVATIVES
-
Page/Page column 90, (2021/11/06)
The invention relates to compounds of Formula (I) wherein X1, X2, X3, Y, R1, R2A, R2B, R3, and R4 are as described in the description; to their preparation, to pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing one or more compounds of Formula (I), and to the use of such compounds as medicaments, especially as Kv7 openers.
COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF
-
Page/Page column 57, (2009/03/07)
Compounds are disclosed that have formula (I): where A, B, L1, X, W, Y, R1, R3, and nlare as defined herein. The compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, anxiety, depression, inflammation, cognitive disorders, weight and eating disorders, Parkinson's disease, Alzheimer's disease, spasticity, addiction, glaucoma, and others.
DIKETOPIPERIDINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS
-
Page/Page column 84-85, (2010/01/30)
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketopiperidine derivatives that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.
COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
-
Page/Page column 29-30, (2009/10/18)
The invention provides compounds of Formula (I): pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.
